Breakthrough UCSF Study: Repurposed Cancer Drugs Show Promise in Reversing Alzheimer’s

by Hal Blake

Breakthrough Study: Cancer Drugs Show Promise in Reversing Alzheimer’s Effects

UCSF Researchers Use Big Data to Identify Existing Medications That May Combat Dementia

A major breakthrough out of UC San Francisco (UCSF) and the Gladstone Institutes has revealed a bold new possibility in the fight against Alzheimer’s: repurposing cancer drugs to restore memory and reduce brain degeneration.

Published in Cell (July 2025), this innovative study is shaking up how researchers approach Alzheimer’s treatment. Rather than developing a brand-new drug from scratch, scientists used big data and artificial intelligence to identify two existing FDA-approved cancer drugsletrozole and irinotecan—that appear to reverse Alzheimer’s effects in lab models.

The Discovery: Flipping Alzheimer’s Gene Activity with Existing Medications

The researchers began by mapping how Alzheimer’s disease alters gene expression in the brain. They then used AI-driven analysis to comb through thousands of approved drugs, looking for compounds that would “flip” that gene signature back to a healthy state.

Two unlikely candidates stood out: letrozole and irinotecan, both originally designed to fight cancer. When used together in Alzheimer’s mouse models, the results were remarkable:

  • 🧠 Reduced brain degeneration

  • 🧠 Restored cognitive function and memory

  • 🧠 Marked protection against tau protein buildup

While each drug individually had limited impact, the combination produced powerful synergistic effects—demonstrating the brain’s remarkable potential for repair, even in late-stage disease models.

Why This Research Could Accelerate Alzheimer’s Treatment

One of the most promising aspects of this discovery is speed. Because letrozole and irinotecan are already FDA-approved, they’ve passed rigorous safety trials. This means:

  • 💊 Faster transition to clinical trials in humans

  • 🧬 Reduced cost and risk of development

  • 🧠 Increased potential for near-term treatment options

Millions of people and their families are waiting for real progress in Alzheimer’s care. Repurposing proven drugs could provide a shorter path to relief, compared to developing entirely new compounds that can take over a decade to approve.

How We Support Breakthroughs Like This at Your Home Sold Guaranteed Realty Advisors LLC

At Your Home Sold Guaranteed Realty Advisors LLC, we proudly donate a portion of every home sold to Alzheimer’s research and care initiatives. We believe in supporting science that changes lives—and this new UCSF study is exactly the kind of hope-driven progress we want to help fund.

When you buy or sell a home with us, you’re not just making a move—you’re making a difference.

💜 Make a Move That Supports a Cure

Want your next real estate transaction to support Alzheimer’s breakthroughs like this one? Partner with a team that gives back.

📞 Call 718-608-4892
Your Home Sold. Guaranteed. Or We’ll Buy It.
💡 Real Estate With a Purpose. Funding a Cure, One Home at a Time.

GET MORE INFORMATION

Hal Blake
Hal Blake

Broker | License ID: 10491210994

+1(718) 608-4892

1110 South Ave, Staten Island, NY, 10314-3403, USA

Name
Phone*
Message
};